Clinical Trial Update: Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction chemotherapy with toripalimab for larynx preservation in resectable laryngeal/hypopharyngeal carcinoma; status not s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer
• Laryngeal Neoplasms

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Laryngeal Cancer, Hypopharynx Cancer | Phase 2 | Status: UNKNOWN